Biotech · Private company
TNF Pharmaceuticals, Inc.
Track this companyFree. Adds TNF Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- MYMD-1 1050mgPhase 2 · SarcopeniaClinicalTrials.gov · fetched Nov 12, 2026
- MYMD-1 600MGPhase 2 · SarcopeniaClinicalTrials.gov · fetched Nov 12, 2026
- MYMD-1 750mgPhase 2 · SarcopeniaClinicalTrials.gov · fetched Nov 12, 2026
- MYMD-1 900mgPhase 2 · SarcopeniaClinicalTrials.gov · fetched Nov 12, 2026
- MYMD-1Phase 1 · Hashimoto DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- MyMD1Phase 1 · UndefinedClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/FrailtyPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05283486 · fetched Nov 12, 2026
- Single Ascending and Multiple Dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male and Female Adult SubjectsPHASE1 · COMPLETED · started Apr 26, 2021ClinicalTrials.gov NCT05077865 · fetched Nov 12, 2026
- Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult SubjectsPHASE1 · COMPLETED · started Jun 11, 2019ClinicalTrials.gov NCT04349761 · fetched Nov 12, 2026